President Donald Trump announced on Tuesday that the US government will purchase 100 million doses of the Moderna experimental coronavirus vaccine, which is currently in human trials at a late stage.
Moderna separately said the deal for its mRNA-1273 vaccine is worth $ 1.525 billion and will give the federal government the opportunity to purchase up to 400 million additional doses. The U.S. has already invested $ 955 million to develop the Moderna vaccine, bringing its total investment to $ 2.48 billion, the company said in a press release Tuesday.
The U.S. government deal with Moderna follows similar deals made with pharmaceutical giants Pfizer and Johnson & Johnson for their potential Covid-19 vaccines.
“We are investing in the development and production of the top six vaccine candidates to ensure a rapid delivery. The military is ready to go. They are ready to deliver a vaccine to the Americans once one is fully approved by the FDA and we “You are very close to that approval,” Trump said during a White House news conference.
The U.S. Department of Health and Human Services previously said it would pay Pfizer and biotech firm BioNTech $ 1.95 billion to produce and distribute 100 million doses of their Covid-19 vaccine with the potential to receive 500 million doses additional. HHS later announced it would give Johnson & Johnson more than $ 1 billion for 100 million doses with the option for an additional 200 million.
The deals are part of the Trump administration’s efforts to accelerate the development, production and distribution of vaccines and treatments to fight the coronavirus under a program called Operation Warp Speed.
“We appreciate the US government’s trust in our mRNA vaccine platform and continued support,” Moderna CEO Stephane Bancel said in a press release.
This is an evolving story. Please check back later for updates.